"10.1371_journal.pone.0100283","plos one","2014-06-25T00:00:00Z","Elisa Mart칤n-Merino; Joan Fortuny; Elena Rivero-Ferrer; Luis Alberto Garc칤a-Rodr칤guez","Centro Espa침ol de Investigaci칩n Farmacoepidemiol칩gica, Madrid, Spain; DS&E - Global Clinical Epidemiology, Novartis Farmaceutica S.A., Barcelona, Spain","Conceived and designed the experiments: EMM JF ERF LAGR. Performed the experiments: EMM. Analyzed the data: EMM. Contributed reagents/materials/analysis tools: EMM. Wrote the paper: EMM JF ERF LAGR.","Elisa Mart칤n-Merino worked at Centro Espa침ol de Investigaci칩n Farmacoepidemiol칩gica (CEIFE), Madrid, Spain, at the moment of performing the study, which has received research funding from Novartis Farmac칠utica S.A. Dr. E. Mart칤n-Merino has no other financial or non-financial competing interests to declare that present a potential conflict of interest or could affect the adherence to all PLOS ONE policies on sharing data and materials.","2014","06","Elisa Mart칤n-Merino","EM츐",4,TRUE,4,1,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
